European Journal of Medical Genetics

Scope & Guideline

Unlocking Genetic Secrets for Better Health Outcomes

Introduction

Welcome to the European Journal of Medical Genetics information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of European Journal of Medical Genetics, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1769-7212
PublisherELSEVIER
Support Open AccessNo
CountryFrance
TypeJournal
Convergefrom 2005 to 2024
AbbreviationEUR J MED GENET / Eur. J. Med. Genet.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The European Journal of Medical Genetics focuses on advancing the understanding of genetic conditions, their clinical implications, and the methodologies for diagnosis and treatment. It serves as a collaborative platform for researchers and healthcare providers to share insights and findings that can enhance the management of genetic disorders.
  1. Genetic Disorders and Syndromes:
    The journal extensively covers a wide range of genetic disorders, including rare diseases, syndromes, and chromosomal abnormalities, providing insights into their clinical presentations, genetic underpinnings, and management strategies.
  2. Clinical Genetics and Genomic Medicine:
    A significant focus is placed on clinical genetics, including the application of genomic technologies such as next-generation sequencing (NGS) in diagnosing genetic conditions, evaluating variants of uncertain significance, and exploring genotype-phenotype correlations.
  3. Patient-Centered Research and Healthcare:
    Research that emphasizes patient experiences, clinical outcomes, and quality of life for individuals with genetic disorders is a core area, highlighting the importance of patient perspectives in genetic counseling and treatment.
  4. Ethics and Policy in Genetic Testing:
    The journal addresses ethical considerations in genetic testing, including informed consent, disclosure of genetic risks, and the implications of genetic information on family dynamics and healthcare practices.
  5. Emerging Genetic Technologies and Therapies:
    The European Journal of Medical Genetics also explores novel genetic therapies and diagnostic technologies, emphasizing their potential impact on patient care and the future of personalized medicine.
The European Journal of Medical Genetics has identified several emerging themes that reflect the current trends in genetic research and clinical practice. These trends highlight the journal's responsiveness to the evolving landscape of medical genetics and the increasing importance of personalized medicine.
  1. Integration of Genomic Technologies:
    There is a growing emphasis on the application of advanced genomic technologies, such as NGS and whole-genome sequencing, in clinical settings to improve diagnostic accuracy and facilitate personalized treatment plans.
  2. Focus on Rare Genetic Disorders:
    An increasing number of studies are dedicated to rare genetic disorders, which often lack sufficient research and understanding, thereby addressing a critical gap in the field of medical genetics.
  3. Patient-Centric Research:
    Research that prioritizes patient perspectives, experiences, and outcomes is on the rise, reflecting a shift towards more holistic approaches in managing genetic conditions and enhancing the quality of care.
  4. Ethical and Social Implications of Genetic Testing:
    As genetic testing becomes more prevalent, there is an emerging focus on the ethical, social, and psychological implications of test results, including issues related to consent, privacy, and familial relationships.
  5. Telemedicine and Remote Genetic Counseling:
    The COVID-19 pandemic has accelerated the integration of telemedicine in genetic counseling, leading to increased research on its effectiveness, accessibility, and impact on patient engagement and satisfaction.

Declining or Waning

While the journal has consistently published high-quality research on genetic disorders, certain themes appear to be declining in focus over recent years. This may reflect shifts in research priorities or advancements in genetic technologies that have rendered previous approaches less prominent.
  1. Traditional Cytogenetic Techniques:
    There is a noticeable decrease in publications focusing solely on traditional cytogenetic methods, such as karyotyping and FISH, as newer genomic technologies like whole-exome sequencing and NGS have become the standard for genetic analysis.
  2. Generalized Genetic Counseling Approaches:
    Research centered on generalized or traditional genetic counseling methods is waning, with a shift towards more personalized and tailored approaches that consider individual patient circumstances and preferences.
  3. Focus on Common Genetic Disorders:
    The journal's emphasis appears to be moving away from common genetic disorders, such as cystic fibrosis or sickle cell disease, towards rare and complex genetic conditions, reflecting a broader interest in under-researched areas.
  4. Basic Genetic Mechanisms:
    There is a decline in studies that primarily discuss basic genetic mechanisms without clinical implications, as the journal increasingly prioritizes research that directly informs clinical practice and patient outcomes.

Similar Journals

Neurology-Genetics

Pioneering Research at the Nexus of Neurology and Genetics.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2376-7839Frequency: 6 issues/year

Neurology-Genetics, an esteemed journal published by LIPPINCOTT WILLIAMS & WILKINS, is at the forefront of advancing the fields of neurology and genetics. With a dedicated Open Access model since 2015, this journal ensures that cutting-edge research is readily available to researchers, professionals, and students worldwide. Operating from the United States, Neurology-Genetics has established a reputable position within the scientific community, as reflected by its impressive rankings in Scopus; it holds a Q1 ranking in clinical neurology and a Q2 ranking in clinical genetics, showcasing its dual commitment to these intertwined fields. With an impact factor that continues to grow alongside its reach, the journal encourages the dissemination of novel findings, innovative methodologies, and critical reviews that contribute to the understanding and treatment of neurological and genetic disorders. Researchers and practitioners are invited to engage with the latest discoveries and discussions, making Neurology-Genetics an essential resource for anyone involved in these dynamic areas of study.

CYTOGENETIC AND GENOME RESEARCH

Fostering innovation in cytogenetics and molecular biology.
Publisher: KARGERISSN: 1424-8581Frequency: 12 issues/year

CYTOGENETIC AND GENOME RESEARCH is a pivotal journal dedicated to the exploration of cytogenetics, genomics, and their applications within clinical genetics and molecular biology. Published by KARGER in Switzerland, this journal aims to foster comprehensive discussions and disseminate impactful research from diverse fields related to genetics. It operates under an open access model, ensuring that researchers, professionals, and students can easily access and contribute to the latest findings. With coverage spanning from 1962 to 2024, CYTOGENETIC AND GENOME RESEARCH continues to serve as a vital resource, despite its current categorization in the Q4 quartile across Genetics and Molecular Biology. It provides an avenue for advancing the understanding of genomic mechanisms and their implications for human health. The journal encourages submissions that delve into cutting-edge methodologies, data interpretation, and theoretical frameworks, thereby playing a crucial role in the advancement of genetic research and its clinical applications.

npj Genomic Medicine

Transforming Discoveries into Clinical Applications
Publisher: NATURE PORTFOLIOISSN: Frequency: 1 issue/year

npj Genomic Medicine is a leading open-access journal published by NATURE PORTFOLIO, specializing in the rapidly evolving areas of genomic medicine, including genetics, molecular biology, and clinical applications. Launched in 2016, the journal has quickly established itself within the academic community, boasting a prestigious Q1 ranking in multiple categories, including Genetics and Molecular Biology, with remarkable positions in both Scopus ranks and percentiles. With an emphasis on innovative genomic research that bridges the gap between laboratory findings and clinical implementation, npj Genomic Medicine aims to provide a platform for researchers, professionals, and students to share significant advancements and insights. Being an open-access journal enhances accessibility to cutting-edge research, ensuring that vital discoveries in genomics can benefit a global audience and facilitate interdisciplinary collaboration. The journal continues to contribute to the forefront of genomic research, impacting both academic scholarship and practical healthcare solutions.

INTERNATIONAL JOURNAL OF HUMAN GENETICS

Empowering Scholars in the Field of Genetics
Publisher: KAMLA-RAJ ENTERPRISESISSN: 0972-3757Frequency: 4 issues/year

INTERNATIONAL JOURNAL OF HUMAN GENETICS is a distinguished publication dedicated to advancing knowledge in the fields of genetics and molecular biology. Published by KAMLA-RAJ ENTERPRISES, this journal explores critical developments and research findings from 2008 to 2016, though its coverage in Scopus has since been discontinued. With an ISSN of 0972-3757 and an E-ISSN of 2456-6330, the journal aimed to foster scholarly dialogue and serve as a resource for researchers, professionals, and students engaged in human genetics. While the journal holds a modest ranking in categories such as Biochemistry and Genetics, it remains a vital source for exploring niche topics within the realm of human genetics. Researchers interested in genetic screening, gene therapy, and clinical genetics will find valuable insights herein. Despite its pause in indexing, the journal continues to contribute to the academic discourse by disseminating critical research that bridges gaps in understanding human genetics.

Frontiers in Genetics

Unlocking the Secrets of Genetics for All
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Genetics is a premier academic journal dedicated to advancing the field of genetics through high-quality, peer-reviewed research. Published by FRONTIERS MEDIA SA in Switzerland since 2010, this Open Access journal provides a platform for researchers and practitioners to disseminate innovative findings across various subfields, including clinical genetics and molecular medicine. With a notable emphasis on interdisciplinary approaches, the journal holds a strong position in the academic landscape, achieving Q2 rankings in key categories such as Genetics and Molecular Medicine in 2023. Not only does Frontiers in Genetics contribute to the scholarly dialogue by publishing impactful studies, but it also promotes accessibility to vital research, ensuring that knowledge is available to a global audience. This journal is a vital resource for researchers, professionals, and students looking to stay at the forefront of genetic discoveries and their applications, reflective of its engagement with contemporary challenges in genetics and healthcare.

Application of Clinical Genetics

Fostering Collaboration in Clinical Genetics Research
Publisher: DOVE MEDICAL PRESS LTDISSN: Frequency: 1 issue/year

Application of Clinical Genetics is a premier open-access journal published by Dove Medical Press Ltd., dedicated to advancing the field of clinical genetics since its inception in 2008. Based in New Zealand, this journal has established itself as a significant resource for researchers, clinicians, and students alike, contributing to the body of knowledge in both genetic medicine and clinical applications. With an impact factor reflecting its contributions to the field, the journal holds positions in the Q2 and Q3 quartiles of the 2023 Genetics categories, showcasing its relevance and scientific merit. Furthermore, it ranks #43 out of 99 in Clinical Genetics and #153 out of 347 in Biochemistry, Genetics, and Molecular Biology, indicating robust performance amongst its peers. The journal’s broad scope, encompassing various aspects of clinical genetics, ensures that it remains at the forefront of critical discussions, innovative research, and applications essential for the progression of personalized medicine. Researchers and professionals are encouraged to explore its openly accessible content that fosters collaboration and the sharing of knowledge in this dynamic and rapidly evolving field.

Global Medical Genetics

Empowering Knowledge in Global Genetics
Publisher: GEORG THIEME VERLAG KGISSN: 2699-9404Frequency: 4 issues/year

Global Medical Genetics is a premier open-access journal dedicated to advancing the field of medical genetics. Published by GEORG THIEME VERLAG KG, this journal has been providing a dynamic platform for disseminating cutting-edge research and clinical findings since its inception in 2020. With the ISSN 2699-9404, it serves as an essential resource for researchers, healthcare professionals, and students who seek to explore the complex interplay between genetics and medicine. The journal aims to foster collaboration and innovation in the genetics community, addressing a diverse range of topics from genetic disorders to the application of genomics in personalized medicine. By providing open access to its content, Global Medical Genetics enhances knowledge sharing and accelerates advancements in healthcare, making it a vital asset for anyone invested in the future of genetics.

CLINICAL GENETICS

Pioneering insights into clinical genetics.
Publisher: WILEYISSN: 0009-9163Frequency: 12 issues/year

CLINICAL GENETICS is a premier journal in the field of genetics, published by Wiley, and is renowned for advancing the understanding of genetic disorders and their clinical applications. With a notable impact factor and ranking in the top quartile (Q1) in both general genetics and clinical genetics as of 2023, this journal is instrumental for researchers, professionals, and students seeking to explore groundbreaking studies and developments in genetics. Since its inception in 1970, CLINICAL GENETICS has continued to publish high-quality, rigorously peer-reviewed research that pushes the boundaries of knowledge in clinical genetics. The journal maintains a strong reputation in its field, currently holding significant positions in Scopus rankings, including 30th out of 99 in clinical genetics, underscoring its relevance and impact in the field. For those interested, the journal's website provides comprehensive access options for current and archived research, making it an essential resource for anyone involved in genetic research and its clinical application.

Genetics Research

Driving Progress in Genetic and Medical Sciences
Publisher: HINDAWI LTDISSN: 0016-6723Frequency: 1 issue/year

Genetics Research, published by HINDAWI LTD, is a distinguished open access journal that has been at the forefront of genetic studies since its inception in 1960. With the transition to open access in 2019, this journal has expanded its accessibility, fostering knowledge dissemination across the global scientific community. Operating out of the United Kingdom, it provides a platform for innovative research in the fields of genetics and molecular biology, encompassing a broad range of topics that are highly relevant to medical sciences. As of 2023, it holds a Q4 classification in Genetics and a Q3 classification in miscellaneous Medicine, reflecting its ongoing commitment to scholarly excellence amidst shifting academic landscapes. While the journal's H-index remains unlisted, its indexed ranking within Scopus, with a rank of #325/328 in the Genetics category highlights the challenges ligated to its niche audience. Nevertheless, it serves as a crucial resource for researchers, professionals, and students eager to contribute to and stay informed on the latest genetic research trends and breakthroughs.

Journal of Pediatric Genetics

Bridging Research and Practice in Pediatric Genetics
Publisher: GEORG THIEME VERLAG KGISSN: 2146-4596Frequency: 4 issues/year

Journal of Pediatric Genetics, published by GEORG THIEME VERLAG KG, is an essential resource in the field of pediatric medicine and genetics. With a focus on the genetic determinants of health and disease in children, this journal aims to advance the knowledge and application of genetic research in pediatric care. Although it has faced challenges in its indexing in recent years, it provides an important platform for practitioners and researchers dedicated to understanding the complexities of pediatric genetics. As evidenced by its position in Scopus ranks—ranked #209 in Pediatrics and #87 in Clinical Genetics—the journal serves a niche yet critical audience seeking to explore the interplay between genetic factors and childhood health outcomes. The Journal of Pediatric Genetics invites scholars and professionals to delve into its rich content, contributing to the ongoing discourse in this vital field, while the absence of open access highlights the journal’s curation of high-quality, peer-reviewed articles that are valued across academia and clinical practices.